Various mechanisms are responsible for the adaptation of prostate cancxer tumors to ADT and include point mutations in androgen receptor, AR amplification, changes of androgen biosynthesis, changes in AR cofactor in prostate cancer cells, AR variants [166,167]. This evidence concerns the gene AR and prostate carcinoma.